ArticleCPT: pharmacometrics & systems pharmacology2021

Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel.

Sreenath M Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.